Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Feb 4, 2011

Premium

AB Sciex this week announced it has appointed Ranier Blair company president.

Previously he was president for North America & Europe of printer company Videojet. Prior to that he was president and CEO of construction chemical company MAPEI Americas and an executive with BASF Group.


Trans-Hit Biomarkers announced that René Paulussen is its new chief operating officer.

Paulussen brings to the Montreal, Quebec-based firm 20 years of experience in scientific research and business management. Before joining Trans-Hit Biomarkers, Paulussen was COO of Genizon Biosciences from 2002.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.